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Objective. We examined personality traits in young women with FM, in order to seek associations with key psychological processes
and clinical symptoms. Methods. Twenty-seven women with FM and 29 age-matched female healthy controls [HC] completed a
series of questionnaires examining FM symptoms, personality and psychological variables. Results. Signiﬁcant diﬀerences between
characteristic FM symptoms (sleep, pain, fatigue, and confusion) as well as for the psychological variables of depression, anxiety,
and stress were found between FM and HC (P<0.001). Neuroticism was the only subscale of the Big Five Inventory that showed
a signiﬁcant diﬀerence between the FM group and HC group [P<0.05]. Within the FM group, there was a signiﬁcant association
between the level of the neuroticism and each of pain, sleep, fatigue, and confusion, depression, anxiety, and stress (P<0.05–
0.01). The association between the level of neuroticism and the level of stress was the strongest of all variables tested (P<0.001).
Conclusion. The personality trait of neuroticism signiﬁcantly associates with the key FM characteristics of pain, sleep, fatigue
and confusion as well as the common co-morbidities of depression, anxiety and stress. Personality appears to be an important
modulator of FM clinical symptoms.
1.Introduction
Fibromyalgia (FM) is a common musculoskeletal pain syn-
drome, characterized by widespread pain and abnormal ten-
derness, associated with variable stiﬀness, fatigue, poor qual-
ity sleep, cognitive disturbance, and emotional distress. It is
found more commonly in women than men (9:1, resp.) and
reported to be present in around 2–5% of the female pop-
ulation within Western societies [1, 2]. As a result of the key
FM symptoms of pain, fatigue, sleep disturbance, and confu-
sion, major quality of life issues arise that have high societal
impact, including medical, psychological, and ﬁnancial [3].
The symptoms of FM relate to disturbed central process-
ing of pain-related and other neural functions [4]. These in
turn are modulated by changes in downward control orig-
inating in emotion-related brain areas, such as the anterior
cingulate cortex and limbic system [5]. Psychological factors,
includinginadequatecopingwithexternalstressors,arecom-
mon in FM [6]. From clinical observation, FM patients often
appear to have personality styles that allow for easy transla-
tion of life events into emotional distress. For instance, pa-
tients with FM are said to be demanding [7], perfectionist,
and have high expectations of themselves and also the people
aroundthem[8].However,althoughpreviouslysuggestedno
speciﬁc FM personality type has been deﬁned [7]. Despite
this, personality is an important ﬁlter that modulates a per-
son’s coping response to psychological stressors [9]a n dm a y
facilitate translation of these stressors to physiological re-
sponses that drive the FM mechanism. Thus aspects of per-
sonality style may modulate the central sensitization mecha-
nism that underlies maintenance and/or exacerbation of
symptoms of FM.
The traits of extraversion and neuroticism have been
widely studied as potential mechanisms that may underlie
certain illnesses [10, 11]. In particular, neuroticism, deﬁning
an enduring tendency to experience negative emotional
states, has been associated with symptoms of depression,
anxiety and high arousal. Patients with migraine, pain,2 Pain Research and Treatment
chronic fatigue, and irritable bowel all score signiﬁcantly
higher on the neuroticism scale compared to healthy con-
trols. These ﬁndings may be biased by health seeking behavi-
our as it itself has also been linked to neuroticism [12]. There
alsohavebeenanumberofotherstudiesthatsuggestacausal
eﬀect between neuroticism and health. Pain mechanisms are
heighted by neuroticism reﬂecting that psychosocial factors
inﬂuence biological mechanisms [12]. Furthermore, both
neuroticism and extraversion have been associated with the
regulation of the autonomic nervous system and pain re-
sponses [13]. Neuroticism will also inﬂuence recall and in
turn memory and is an issue pertinent to patients with FM
[14].
Limited and inconsistent [13] studies have investigated
the role of personality in the development, maintenance, and
exacerbation of symptoms associated with FM. Previous
studiesfocussedonpersonalityusingscalesbasedonlevelsof
psychopathology, such as the Minnesota Multiphasic Per-
sonality Inventory [MMPI I/2], or take a psychobiological/
biological relevance approach using scales such as the Tem-
perament and Character Inventory (TCI) or Karolinska scale
of personality [15].It has been shown that high levels of neu-
roticismlinktoincreasedperceptionofpainandothersymp-
toms associated with FM [16, 17]. This may occur through
the eﬀect of personality on the type of coping techniques
used to deal with pain rather than a direct eﬀect on the pain
itself [12, 17].
The key domains contributing to the clinical phenotype
of FM, namely, pain, poor sleep, fatigue, cognitive dys-
function (confusion), emotional distress (anxiety and
depression), and stress are well deﬁned within the American
College of Rheumatology [ACR] 1990 classiﬁcation [18]a n d
the2010diagnostic[19]criteriaforFM.Weaimedtoexplore
whether personality traits inﬂuence these characteristic
symptoms of FM. We surveyed young women with FM in
order to minimize long-term secondary and adaptive eﬀects
of the condition on these FM outcomes. We speciﬁcally
wished to see if the characteristic FM symptoms of pain,
sleep, confusion, depression, anxiety, and stress associate
with personality traits and if so how these factors might
interlink.
2. Methods
2.1. Ethics. Ethics approval was obtained through relevant
committeesofMonashUniversityandMonashMedicalCen-
tre, Melbourne, Australia.
2.2. Subjects. The participants in this study consisted of vol-
unteer women who were sourced from a variety of areas in-
cluding a FM self-management program, notices in local
news-papers, a ﬁbromyalgia treatment clinic, and local rheu-
matologists. Twenty-ﬁve female FM patients fulﬁlling ACR
1990 classiﬁcation criteria and 27 female HCs, all healthy
individuals with no pain condition and recruited by word of
mouth were identiﬁed. All were under age of 39 years of age.
2.3. Procedures. All participants were sent written informa-
tion regarding the study along with a consent form which,
when signed, was followed by a series of questionnaires.
These included the Fibromyalgia Impact Questionnaire [20],
theProﬁleofMoodStates[21],andthePerceivedStressScale
[22]. Participating FM women were also contacted 12
months later to complete the same battery of questionnaires,
with a response rate of 56%.
2.4. Instruments. The following instruments were applied to
all FM and HC subjects at time zero and to 56% of FM pa-
tients 12 months later.
(1) The Big 5 Personality Inventory (BFI) [11]: a vali-
dated 44-item personality scale, scored as 1 (disagree
strongly) through 5 (agree strongly) to indicate the
extent of agreement with the items. The 44 items
comprise 5 subscales of extraversion, agreeableness,
conscientiousness, neuroticism, and openness.
(2) Fibromyalgia Impact Questionnaire (FIQ) [20]: a
validated 20-item functional ability questionnaire,
which measures how an individual’s symptom char-
acteristics impact their daily functioning for the pre-
ceding week. Individual subscales include sleep,
depression, anxiety, and pain and use a 0 to 10cm
visual analogue scale (VAS), measuring left of line for
“no impact of subscale” through to the far right,
“worst possible impact”.
(3) Perceived Stress Scale (PSS) [22]: a validated scale
that assesses the degree an individual experiences
feelings of being overwhelmed by stressful life events
over the past month. The scale is a 10-item, 5-point
likert scale ranging from 0 (never) to 4 (very often)
with scores ranging from 0 to 40.
(4) Proﬁle of Mood States (POMS) [21] confusion sub-
scale: a validated scale that measures individual
a s p e c t so fm o o da sw e l la sat o t a lo v e r a l lm o o d
score. The POMS identiﬁes adjective words that de-
scribe feelings that are indicative of mood states. The
questionnaire asks individuals to rate on a scale
from zero (not at all) to four (extremely) which
best describes how they have felt over the past
week. The scale includes a total of 65 deﬁnitions that
represent the 6 subscales that include Tension-Anx-
iety, Depression-Dejection, Anger-Hostility, Vigour,
Fatigue, and Confusion. A total mood score is
obtained by summing all subscale scores with vigour
inversed. The subscale of confusion was used to
represent the cognitive dysfunction seen in FM. The
single word items that reﬂect confusion include be-
wil-dered, confused, unable to concentrate, forgetful,
uncertain, and eﬃcient (score reversed).
2.5. Statistical Analysis. Initial descriptive analysis was con-
ducted, along with normality checks, using SPSS (PASW
version). Chi-squared test was used to test for diﬀerences in
groupdemographics.t-Tests, means and standard deviations
were used to explore the diﬀerences between groups in
symptom characteristics and stability of personality traits.
ANOVAs were performed to compare the diﬀerences be-Pain Research and Treatment 3
tween the groups that explored levels of neuroticism (high,
medium, and low) for symptom characteristics of FM within
the FM group. Bivariate (Pearson) correlation was used to
compare the relationships between the variables of FM and
levels of neuroticism.
3. Results
The demographic characteristics of the total FM group and
the HC group at time zero are shown in Table 1.T h eg r o u p s
were matched for age (P = 0.1). At both time zero and at
12 months followup the FM group reported that 100% were
married and the majority were working part time in either
semi- or fully professional roles, holding tertiary qualiﬁca-
tions with income levels around $AUD 20,000. Compared to
HCs more FM patients were part-time workers and had
lower mean incomes.
Table 2 shows the personality traits in the FM subgroup
atthetwotimeperiodsofthestudy,timezeroand12months
later. There was stability within the subscales over 12 months
with the exception of the subscale of agreeableness. This
conﬁrms previous research that shows that the BFI opera-
tional deﬁnition of neuroticism is robust over time in this
FM population.
Table 3 details symptom characteristics and mean per-
sonality traits in FM and HC groups. As expected, all the
symptom characteristics traditionally associated with FM
were found to be signiﬁcantly diﬀerent between the FM and
HC groups. Sleep and fatigue were rated higher than pain on
the VAS scales in both groups. In contrast, the subscales of
personality showed a signiﬁcant diﬀerence only for the scale
of neuroticism.
The relationship between neuroticism and the symptoms
that are associated with FM is shown in Table 4.I ti se v i d e n t
that most symptoms of FM are signiﬁcantly inﬂuenced by
neuroticism in the FM group with the exception of pain
and confusion. The correlation showed moderate-to-strong
positive relationships suggesting a linear relationship that as
the level of neuroticism increases so does the level of FM
symptoms. There are strong associations between neuroti-
cism and stress and anxiety and a relatively strong rela-
tionship between neuroticism and depression.
The association between neuroticism and FM symptoms
was explored further, by equally separating for low, medium,
and high levels of neuroticism, as shown in Table 5. Signif-
icant diﬀerences were found between all high and low neu-
roticism groups for each of the characteristic symptoms of
FM, with the exception of stress. There were statistically
signiﬁcantdiﬀerencesbetweenallthreelevelsofneuroticism,
high, medium, and low, and stress, indicating a gradient
eﬀect of neuroticism severity and level of stress. In contrast,
a ceiling eﬀect was found for pain, with the group that had
a medium level of neuroticism reporting a higher mean for
pain than the group categorised as having high levels of neu-
roticism. It is noted that even with the high levels of neu-
roticism the levels of depression and anxiety would only be
clinicallyratedasmoderate.Higherlevelsoffatigueandwor-
sening quality of sleep were present as the level of neuroti-
cism increased.
4. Discussion
The cause for ﬁbromyalgia remains unclear. However, in-
creased sensitivity and responsiveness of pain-related neural
systems in the spinal cord and brain has been shown through
numerous studies [23]. This change in spinal cord dorsal
horn neurone function allows innocuous stimuli to access
the pain system and cause pain responses in the brain. Low
threshold mechanoreceptors, associated with muscle and
joint tone and movement, for instance, provide signiﬁcant
sensory input to facilitate this process [24]. The spinal cord
dorsal horn pain-related neuron sensitivity in turn is inﬂu-
enced by downward control mechanisms from the midbrain
and from the brain itself. These involve, in particular, the
emotionlinkedregionsofthebrainsuchasthefrontalcortex,
the anterior cingulate gyrus, the amygdale, and other limbic
structures [5, 25, 26].
This “top-down” model ﬁts with the biopsychosocial
model of ﬁbromyalgia [27]. Central psychological factors,
acting under the inﬂuence of external social stressors, result
in emotional distress that in turn may activate physiological
stress responses if modifying “ﬁlters” allow. These ﬁlters
include the individual’s personality, belief system, sleep pat-
tern,andotherpsychosocialfactors;eachpossiblyfacilitating
or impeding outcomes. Patients with ﬁbromyalgia have been
characterisedashaving signiﬁcant background psychological
distress [28]. Increased activity of the autonomic nervous
system is present in many works [29]. In others there is
evidence of poor adaptation to routine stressors with in-
creasedratesofcatastrophizationandpoorcopingskillsindi-
cating a link between intrinsic stress coping styles and inputs
from the outside world [30].
In this study, we were interested in the role of personality
in this process. Personality has been diﬃcult to be clearly
deﬁned and many diﬀerent systems and approaches have
beenusedtotrytobetterdeﬁnetheessentialelementsofper-
sonality [31]. We hypothesize that certain personality styles
are able to inﬂuence interpretation of everyday stressors and
eitherbluntoramplifysubsequentphysiologicalresponsesin
the brain. We thus see personality as a modifying ﬁlter be-
tween external stressors and subsequent physiological re-
sponses, particularly those that relate the emotional part of
the brain to the downward control systems inﬂuencing the
spinal cord sensory sensitivity centres. Hence, we see a link
between psychological inﬂuences and the clinical features of
ﬁbromyalgia, as expressed by the phenotype of widespread
pain, widespread tenderness, dermatographia, muscle stiﬀ-
ness, and related clinical events.
There are numerous variables that might inﬂuence stress
reactivityinaﬁbromyalgiapopulation. Thecharacteristicsof
the condition itself, with resultant pain, fatigue, sleep dis-
turbance, and signiﬁcant disability, will cause stress and
otherfeedbackeventsinitsownright.Inordertolessenthese
eﬀects we chose young female patients in order to deﬁne a
population less inﬂuenced by age and accumulative life stress
factors.
The clinical characteristics of our ﬁbromyalgia popula-
tion, when compared to healthy controls, showed typical
scores on visual analogue scales for the domains of pain,4 Pain Research and Treatment
Table 1: Demographic characteristics of ﬁbromyalgia (FM) and healthy control (HC) groups.
FM HC Signiﬁcance




















Average Income (Australian Dollar) < $20,000 $41–60,000 P<0.05
Table 2: Paired Sample t-Statistics for personality traits in








sleep, fatigue, depression, and anxiety. In our ﬁbromyalgia
population we found the depression and anxiety scores to be
around 4.7 out of 10 suggesting that this group had only
moderate levels of mood disturbance. We also found that in
this group sleep and fatigue abnormalities rated higher than
pain.
In the study we used the big 5 personality inventory that
examines traits linked to diﬀerent personality styles. There
are very limited studies into personality traits and FM that
have used the big 5 inventory, however, neuroticism and to
a lesser extent extraversion have been examined through use
of other personality measures [17]. Personality is generally
consideredtobeaconsistentcollectionofaﬀective,cognitive,
and behavioural patterns. Underlying traits or characteristics
represent both the similarities and the diﬀerences that typify
the individual together with how, when, and why people
adapt within certain environments. One approach to per-
sonality is a trait perspective which is reﬂected in the com-
ponents of the “The big 5” (BFI). This instrument is a proﬁle
ofﬁvehierarchicaldescriptorsthataresaidtocaptureabroad
level of concepts and commonalities among most of the
existing systems of personality description and hence it pro-
vides an integrative model for personality research [10, 11].
These 5 traits are deﬁned by descriptors presented on a
continuum. In the BFI neuroticism is deﬁned in terms of “is
depressed, worries a lot, can be moody, gets nervous easily,
and remains calm (scored in reverse)”, all statements that
reﬂect elements of anxiety. However, the descriptors also
include “becoming upset, tense, worried, and not relaxed.”
A number of studies show links between development and
exacerbation of chronic health conditions in general and
the personality style deﬁned as neuroticism, with a linear
increase of diﬀerent pathologies to increasing neuroticism
[12].
We show that the BFI is stable over time in this ﬁbro-
myalgia population, with the exception of the trait of agree-
ableness, which unlike other traits, did show a signiﬁcant
diﬀerence between patients examined over a twelve-month
period. The other four characteristics of the big 5 scale, that
is, neuroticism, extraversion, openness, and conscientious-
ness, showed no signiﬁcant diﬀerence over the twelve-month
period. When the age-matched ﬁbromyalgia group was com-
pared to a group of healthy pain-free controls it was noted
that only neuroticism was signiﬁcantly diﬀerent between the
twogroups.Thisobservationsupportspreviousﬁndingsthat
ﬁbromyalgia subjects have more neurotic traits than healthy
controls [32].
In this current study of younger female FM patients there
was no signiﬁcant relationship in the total group between
neuroticism and pain or confusion. Although this mightPain Research and Treatment 5
Table 3: Independent t-tests between ﬁbromyalgia patients (FM) and healthy controls (HC) for symptom characteristics and personality
traits (means ± standard deviation).
FM HC t df P
Symptom Characteristic
Pain 6.36 ±2.25 0.17 ±0.10 13.18 47 0.000
Fatigue 8.52 ±1.33 2.88 ±2.44 10.16 48 0.000
Sleep 8.24 ±1.67 3.33 ±2.75 7.71 50 0.000
Confusion 11.0 ±4.45 6.19 ±5.87 3.31 50 0.01
Depression 4.72 ±2.49 1.41 ±2.56 4.72 50 0.000
Anxiety 4.76 ±3.07 1.74 ±2.16 4.13 50 0.000
Stress 30.16 ±5.89 24.15 ±7.30 3.25 50 0.01
Personality traits
Extraversion 24.35 ±6.29 27.43 ±5.84 −1.68 50 NS
Neuroticism 25.95 ±5.22 23.91 ±6.04 2.36 50 0.05
Agreeableness 35.21 ±3.94 33.57 ±4.03 1.07 50 NS
Conscientiousness 35.10 ±4.24 33.29 ±5.44 1.20 50 NS
Openness 35.20 ±5.99 34.43 ±1.02 0.44 50 NS
NS: not signiﬁcant.
Table 4: Relationships between neuroticism and symptom charac-













that this reﬂects methodology of assessment and ceiling
eﬀects for these variables. Additionally, potential confound-
ing variables may be impacting on this relationship, such
as control, and these require more detailed investigation.
There was however positive moderate-to-strong correlations
between neuroticism and fatigue, sleep, depression, anxiety,
and stress, all key symptoms of FM.
When levels of neuroticism were arbitrarily classiﬁed
as low, medium, or high, there was, in general, signiﬁcant
correlation between moderate and higher levels of neuroti-
cism and FM symptoms compared to lower levels. There was
less variation between the mid-to-high levels of neuroticism
than there was between the low-to-mid levels of neuroticism.
For instance, for pain a ceiling eﬀect was present with no
statistically signiﬁcant diﬀerence between pain in the
moderate-to-high levels of neurotic traits. Stress was a
striking exception, being signiﬁcantly diﬀerent between all
levels of neuroticism and showing a clear gradient eﬀect with
severityofFMsymptoms.Stresshasbeennotedtobeamajor
factor in the exacerbation and potential development of FM
[6]. Thus as neuroticism traits increase in the patient
with FM the more symptoms that patient will expe-
rience. As previously stated, the neuroticism trait as
deﬁned by the Big 5 inventory is based on ques-
tions that, in many instances, link to how an indi-
vidual perceives and reacts to stress. Hence there is
some commonality in components of the various instru-
ments used to measure, for instance neuroticism, stress, or
anxiety. While this may account for some of the positive
associations between these features it is felt that the trait
deﬁned as neuroticism is a well-accepted and stand-alone
entitythatdeﬁnesacertainpersonalitystyle.Assuchthetrait
in its own right appears as an important component of FM.
The pain, sleep change, and fatigue of FM may be further
aggravated by pain-associated maladaptive coping tech-
niques and negative pain beliefs, each also likely inﬂuenced
by personality. With such interacting feedback inﬂuencing
on the FM process it is therefore a challenge to identify how
exactly personality impacts on ﬁbromyalgia. This is further
complicated by the multifaceted nature of personality with
no simple assessment tool accounting for all its aspects.
Personality has been suggested to be a factor that in-
creases the risk for the development of FM [9, 33–35]. In
this study personality, speciﬁcally neuroticism was found to
modulate symptoms associated with FM, in particular stress
levels. Neuroticism also modulated sleep quality and fatigue.
Thus with increased levels of neuroticism the individual has
poorer quality of sleep, higher levels of fatigue, and increased
levels of stress.
As this is a cross-sectional study only limited associations
can be drawn from this analysis. In addition, the duration of
pain was not part of the analysis and hence any conclusions
thatpotentially associatebeing youngerwithlessinﬂuenceof
neuroticism need to be taken cautiously. However, it is pos-
sible that being younger will equate to less time to become
entrenched in behaviours that reinforce factors that in turn6 Pain Research and Treatment
Table 5: ANOVA results for levels of the neuroticism trait of low (1), medium (2), and high (3) according to the ﬁbromyalgia group
individual symptom characteristic.
Neuroticism level
F df P Mean ± SD Groups P
Symptom
Pain: 4.48 2, 46 0.05 (1) 4.75 ±1.39 1-2 0.05
(2) 6.80 ±2.14 1–3 0.05
(3) 6.28 ±2.11
Sleep: 7.64 2, 49 0.001 (1) 3.31 ±3.07 1-2 0.05
(2) 6.37 ±2.87 1–3 0.01
(3) 7.18 ±3.05
Fatigue: 7.10 2, 47 0.002 (1) 3.31 ±2.98 1-2 0.01
(2) 6.65 ±3.20 1–3 0.01
(3) 7.00 ±3.06
Confusion: 6.44 2, 49 0.003 (1) 4.63 ±3.46 1–3 0.01
(2) 10.05 ±6.11 1-2 0.01
(3) 10.41 ±5.44
Depression: 14.60 2, 49 0.001 (1) 0.44 ±0.89 1-2 0.01
(2) 3.42 ±2.99 1–3 0.000
(3) 4.94 ±2.70
Anxiety: 12.47 2, 49 0.000 (1) 0.88 ±1.09 1-2 0.05
(2) 3.32 ±2.83 1–3 0.000
(3) 5.34 ±3.03
Stress: 25.67 2, 49 0.000 (1) 19.88 ±4.16 1-2 0.000
(2) 2. 28.05 ±5.62 1–3 0.000
(3) 3. 32.65 ±5.50 2-3 0.05
further contribute to FM [36]. There are no other studies on
neuroticism in young females with FM.
A number of demographic diﬀerences between the FM
group and the HC group might imply that there are a num-
ber of psychosocial variables that may inﬂuence the ﬁndings.
Past studies have noted that often the participants that enrol
in such studies are not reﬂective of the general population
of FM [37] indicating caution in generalizing these ﬁndings
to the total FM population. The fact that many of these par-
ticipants had been involved in previous treatment programs
suggests that this group potentially may be more proactive
and this could be reﬂected in their personality style. Addi-
tionally this study needs to be replicated in an older age
population.
In this study we found that certain personality styles,
speciﬁcally neuroticism, associate with clinical features of
FM. It is proposed therefore that personality is an important
ﬁlter that modulates a person’s response to psychological
stressors and is involved in translation of these stressors to
physiologicalresponsesdrivingtheﬁbromyalgiamechanism.
This area of research is complex but important to the under-
standing of ﬁbromyalgia, especially from a biopsychosocial
approach that integrates mind and body.
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